August 13, 2022

Viagra may now be available without a prescription

The Medicines and Health Products Regulatory Agency (MHRA) has announced that Viagra Connect (containing 50 mg of sildenafil) will be officially classified from a prescription only drug (POM) to a pharmacy drug (P) . This means that it could be available without a prescription for men over 18 with erectile dysfunction.

The move was made following a reassuring safety assessment of Viagra Connect, an opinion from the Commission on Human Medicines and a public consultation earlier this year with a positive result.

If it is marketed, the drug will be sold in pharmacies after discussion with the pharmacist. Pharmacists will be able to determine if the treatment is appropriate for the patient and will be able to advise on erectile dysfunction, the use of the medication, potential side effects and whether further consultation with a general practitioner is necessary.

Viagra Connect will not be sold to people with serious cardiovascular disorders; at high cardiovascular risk; Hepatic insufficiency; severe renal failure; or by taking certain drugs in interaction. The use of Viagra Connect in these groups of men should continue to be under the supervision of a physician.

Making this drug more widely available will help steer men who might not otherwise seek help from the healthcare system and steer them away from the risks of buying drugs from illegally operating websites.

Erectile dysfunction drugs are a popular target for criminals who sell unauthorized and counterfeit drugs. Over the past 5 years, MHRA investigators have seized over £ 50million in unauthorized and counterfeit erectile dysfunction drugs.

Mick Foy, head of MHRA’s Drug Vigilance and Risk Management Group, said: “This decision is good news for men’s health. The decision to make Viagra Connect more accessible will encourage men to seek help within the dysfunctional system. “

“Erectile dysfunction can be a debilitating condition, so it’s important for men to feel they have quick access to quality, legitimate health care, and that they don’t need to turn to online supplies. counterfeits that could have potentially serious side effects. “

This article has been republished from material provided by the Medicines and Health Products Regulatory Agency. Note: Material may have been modified for length and content. For more information, please contact the cited source.


Source link